Moreover, a dual inhibitor targeting both the Bromo- and extra-terminal Motif (BET) protein BRD4 and histone acetyltransferase EP300/CBP was found to inhibit oncogenic Ras signaling and enhance the efficacy of anti-PD-1 ICB in PC mouse models [171]. This evidence concerns the gene BRD4 and pachyonychia congenita.